Cite
HARVARD Citation
Peyraga, G. et al. (2017). Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatin. Anti-cancer drugs. 28 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Peyraga, G. et al. (2017). Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatin. Anti-cancer drugs. 28 (2), p. . [Online].